Home > Insider Trading > Filing (0001093557-20-000232)

Filing Details

Accession Number:: 0001093557-20-000232
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-26 19:03:46
Reporting Period:: 2020-08-24

Accepted Time:: 2020-08-26 19:03:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1534342	Donald Abbey	6340 Sequence Drive San Diego CA 92121	Evp Quality And Regulatory Aff	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-08-24	1,826	$421.46	67,881	No	4	S	Direct
Common Stock	Disposition	2020-08-24	2,493	$423.18	65,388	No	4	S	Direct
Common Stock	Disposition	2020-08-24	1,500	$423.69	63,888	No	4	S	Direct
Common Stock	Disposition	2020-08-24	400	$425.15	63,488	No	4	S	Direct
Common Stock	Disposition	2020-08-24	1,000	$426.66	62,488	No	4	S	Direct
Common Stock	Disposition	2020-08-24	1,227	$427.61	61,261	No	4	S	Direct
Common Stock	Disposition	2020-08-24	1,320	$428.58	59,941	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019, and amended effective May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey.
This transaction was executed in multiple trades at prices ranging from $421.119 to $421.95. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
This transaction was executed in multiple trades at prices ranging from $422.409 to $423.39. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $423.49 to $424.21. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $424.74 to $425.565. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $426.254 to $426.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $427.41 to $428.19. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $428.52 to $428.88. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.